Effects of in vivo and in vitro administration of ghrelin, leptin and neuropeptide mediators on pulsatile gonadotrophin-releasing hormone secretion from male rat hypothalamus before and after puberty
gonadotrophin-releasing hormone; leptin; ghrelin; AgRP; alpha-MSH; CRF; rat
Abstract :
[en] The present study aimed to investigate the effects of leptin and ghrelin on pulsatile pulsatile gonadotrophin-releasing hormone (GnRH) secretion in vitro with emphasis on neuropeptide mediators and changes between prepuberty (15 days) and sexual maturity (50 days) in the male rat. When hypothalamic explants were studied 90 min after an intraperitoneal injection of leptin, ghrelin or agouti-related protein (AgRP) at 15 days, the GnRH interpulse interval (IPI) was significantly increased by ghrelin and AgRP and decreased by leptin. At 50 days, an increase in GnRH IPI was also caused by ghrelin and AgRP. When the peptides were directly incubated with the explants, the effects of leptin and AgRP in vitro were consistent with those seen after in vivo administration. By contrast, ghrelin resulted in a reduction of GnRH IPI and this was observed at 15 days only. To delineate the neuropeptide mediators of leptin and the effects of ghrelin in the hypothalamus, various hypothalamic neuropeptides and antagonists were used in vitro. At 15 days, the GnRH IPI was significantly decreased after incubation with cocaine and amphetamine-regulated transcript (CART), alpha-melanocyte-stimulating hormone, corticotrophin-releasing factor (CRF) and neuropeptide Y (NPY). The reduction of GnRH IPI caused by leptin was partially prevented by either an anti-CART antiserum or SHU 9119, a melanocortin MC3/MC4 receptor antagonist or a CRF receptor antagonist. The NPY-Y5 receptor antagonist did not influence the effects of leptin whereas that antagonist totally prevented the decrease in GnRH IPI caused by ghrelin. The ghrelin-induced reduction of GnRH IPI was partially prevented by SHU 9119. When used alone, SHU 9119 or a CRF-receptor antagonist resulted in increased GnRH IPI at 50 days while they had no effects at 15 days. The NPY-Y5 receptor antagonist resulted in increased GnRH IPI at 15 and 50 days. In conclusion, leptin and ghrelin show opposing effects on pulsatile GnRH secretion after administration in vivo whereas they both have stimulatory effects in vitro. Such effects involve consistently the anorectic peptides CART and CRF for leptin that are mainly active at 15 days. The melanocortigenic system appears to mediate the effects of both leptin and ghrelin. The effects of ghrelin also involve NPY receptors and operate effectively before and at sexual maturity.
Gerard, Arlette ; Centre Hospitalier Universitaire de Liège - CHU > Pédiatrie
Parent, Anne-Simone ; Université de Liège - ULiège > Département des sciences cliniques > Pédiatrie
Bourguignon, Jean-Pierre ; Université de Liège - ULiège > Département des sciences cliniques > Pédiatrie
Language :
English
Title :
Effects of in vivo and in vitro administration of ghrelin, leptin and neuropeptide mediators on pulsatile gonadotrophin-releasing hormone secretion from male rat hypothalamus before and after puberty
Publication date :
March 2007
Journal title :
Journal of Neuroendocrinology
ISSN :
0953-8194
eISSN :
1365-2826
Publisher :
Blackwell Publishing, Oxford, United Kingdom
Volume :
19
Issue :
3
Pages :
181-188
Peer reviewed :
Peer Reviewed verified by ORBi
Funders :
F.R.S.-FNRS - Fonds de la Recherche Scientifique [BE] Faculty of Medicine, University of Liège BSGPE - Belgian Study Group for Pediatric Endocrinology [BE]
Williams G, Bing C, Cai XJ, Harrold JA, King PJ, Liu WH. The hypothalamus and the control of energy homeostasis: Different circuits, different purposes. Physiol Behav 2001; 74: 683-701.
Kalra SP, Dube MG, Pu S, Xu B, Horvath TL, Kalra PS. Interacting appetite-regulation pathways in the hypothalamic regulation of body weight. Endocrine Rev 1999; 20: 68-100.
Frisch RE, McArthur JW. Menstrual cycles: Fatness as a determinant of minimum weight for height necessary for their maintenance or onset. Science 1974; 185: 949-951.
Cheung CC, Thornton JE, Nurani SD, Clifton DK, Steiner RA. A reassessment of leptin's role in triggering the onset of puberty in the rat and mouse. Neuroendocrinology 2001; 74: 12-21.
Lebrethon MC, Vandersmissen E, Gérard A, Parent AS, Junien JL, Bourguignon JP. In vitro stimulation of the prepubertal rat gonadotrophinreleasing hormone pulse generator by leptin and neuropeptide Y through distinct mechanisms. Endocrinology 2000; 141: 1464-1469.
Parent AS, Lebrethon MC, Gérard A, Vandersmissen E, Bourguignon JP. Leptin effects on pulsatile gonadotropin releasing hormone secretion from the adult rat hypothalamus and interaction with cocaine and amphetamine regulated transcript peptide and neuropeptide Y. Regul Pept 2000; 92: 17-24.
Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999; 402: 656-660.
Wren AM, Small CJ, Ward HL, Murphy KG, Dakin CL, Taheri S, Kennedy AR, Roberts GH, Morgan DG, Ghatei MA, Bloom SR. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 2000; 141: 4325-4328.
Cowley MA, Smith RG, Diano S, Tschop M, Pronchuk N, Grove KI, Strasburger CJ, Bidlingmaier M, Esterman M, Heiman ML, Garcia Segura LM, Nillni EA, Mendez P, Low MJ, Sotonyi P, Friedman JM, Liu H, Pinto S, Colmers WF, Cone RD, Horvath TL. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 2003; 37: 649-661.
Fernandez-Fernandez R, Tena-Sempere M, Aguilar E, Pinilla L. Ghrelin effects on gonadotrophin secretion in male and female rats. Neurosci Lett 2004; 362: 103-107.
Fernandez-Fernandez R, Tena-Sempere M, Navarro VM, Barreiro ML, Castellano JM, Aguilar E, Pinilla L. Effects of ghrelin upon gonadotropin-releasing hormone and gonadotropin secretion in adult female rats: In vivo and in vitro studies. Neuroendocrinology 2005; 82: 245-255.
Vulliemoz NR, Xiao E, Xia-Zhang L, Germond M, Rivier J, Ferin M. Decrease in luteinizing hormone pulse frequency during a five-hour peripheral ghrelin infusion in the ovariectomized rhesus monkey. J Clin Endocrinol Metab 2004; 89: 5718-5723.
Martini AC, Fernández-Fernández R, Tovar S, Navarro VM, Vigo E, Vazquez MJ, Davies JS, Thompson NM, Aguilar E, Pinilla L, Wells T, Dieguez C, Tena-Sempere M. Comparative analysis of the effects of ghrelin and unacylated ghrelin upon luteinizing hormone secretion in male rats. Endocrinology 2006; 147: 2374-2382.
Bourguignon JP, Gérard A, Alvarez Gonzalez ML, Franchimont P. The neuroendocrine mechanism of onset of puberty: Sequential reduction in activity of inhibitory and facilitatory N-methyl-D-aspartate receptors. J Clin Invest 1992; 90: 1736-1174.
Lebrethon MC, Vandersmissen E, Gérard A, Parent AS, Bourguignon JP. Cocaine and amphetamine-regulated-transcript peptide mediation of leptin stimulatory effect on the rat gonadotropin-releasing hormone pulse generator in vitro. J Neuroendocrinol 2000; 12: 383-385.
Chen HY, Trumbauer ME, Chen AS, Weingarth DT, Adams JR, Frazier EG, Shen Z, Marsh DJ, Feighner SD, Guan XMYeZ, Nargund RP, Smith RG, Van Der Ploeg LHT, Howard AD, Macneil DJ, Qian S. Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein. Endocrinology 2004; 145: 2607-2612.
Bourguignon JP, Gérard A, Franchimont P. Direct activation of GnRH secretion through different receptors to neuroexcitatory amino acids. Neuroendocrinology 1989; 49: 402-408.
Hartter DE, Ramirez VD. Responsiveness of immature versus adult male rat hypothalami to dibutyryl cyclic AMP-and forskolin-induced LHRH release in vitro. Neuroendocrinology 1985; 40: 476-482.
Traebert M, Reidiger T, Whitebread S, Scharrer E, Schmid HA. Ghrelin acts on leptin-responsive neurones in the rat arcuate nucleus. J Neuroendocrinol 2002; 14: 580-586.
Reymoso R, Ponzo OJ, Szwarcfarb B, Rondina D, Carbone S, Rimoldi G, Scacchi P, Moguilevsky JA. Effect of leptin on hypothalamic release of GnRH and neurotransmitter amino acids during sexual maturation in female rats. Exp Clin Endocrinol Diabetes 2003; 111: 274-277.
Kalra SP, Kalra PS. NPY-an endearing journey in search of a neurochemical on/off switch for appetite, sex and reproduction. Peptides 2004; 25: 465-471.
Gonzales C, Voirol M-J, Giacomini M, Gaillard RC, Pedrazzini T, Pralong FP. The neuropeptide Y Y1 receptor mediates NPY-induced inhibition of the gonadotrope axis under poor metabolic conditions. FASEB J 2004; 18: 137-139.
Clarke IJ, Backholer K, Tilbrook AJ. Y2 receptor-selective agonist delays the estrogen-induced luteinizing hormone surge in ovariectomized ewes, but Y1-receptor-selective agonist stimulates voluntary food intake. Endocrinology 2005; 146: 769-775.
Riediger T, Traebert M, Schmid HA, Scheel C, Lutz TA, Scharrer E. Site-specific effects of ghrelin on the neuronal activity in the hypothalamic arcuate nucleus. Neurosci Lett 2003; 341: 151-155.
Fernandez-Fernandez R, Aguilar E, Tena-Sempere M, Pinilla L. Effects of polypeptides YY3-36 upon luteinizing hormone-releasing hormone and gonadotropin secretion in prepubertal rats: In vivo and in vitro studies. Endocrinology 2005; 146: 1403-1410.
Cheung CC, Clifton DK, Steiner RA. Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus. Endocrinology 1997; 138: 4489-4492.
Thornton JE, Cheung CC, Clifton DK, Steiner RA. Regulation of hypothalamic proopiomelanocortin mRNA by leptin in ob/ob mice. Endocrinology 1997; 138: 5063-5066.
Cowley MA, Smart JL, Rubinstein M, Cerdan MG, Diano S, Horvath TL, Cone RD, Low MJ. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 2001; 411: 480-484.
Fan W, Boston BA, Kesterson RA, Hruby VJ, Cone RD. Role of melanocortigenic neurons in feeding and the agouti obesity syndrome. Nature 1997; 385: 165-168.
Seeley RJ, Yagaloff KA, Fisher SL, Burn P, Thiele TE, van Dijk G, Baskin DG, Schwartz MW. Melanocortin receptors in leptin effects. Nature 1997; 390: 349.
Leranth C, MacLusky NJ, Shanabrough M, Naftolin F. Immunohistochemical evidence for synaptic connections between pro-opiomelanocortin-immunoreactive axons and LH-RH neurons in the preoptic area on the rat. Brain Res 1988; 449: 167-176.
Khong K, Kurtz SE, Sykes RL, Cone RD. Expression of functional melanocortin-4 receptor in the hypothalamic GT1-1 cell line. Neuroendocrinology 2001; 74: 193-201.
Watanobe H. Leptin directly acts within the hypothalamus to stimulate gonadotropin-releasing hormone secretion in vivo in rats. J Physiol 2002; 545: 225-268.
Hohmann JG, Teal TH, Clifton DK, Davis J, Hruby VJ, Han G, Steiner RA. Differential role of melanocortins in mediating leptin's central effects on feeding and reproduction. Am J Physiol Regul Comp Physiol 2000; 278: R50-R59.
Raposinho PD, Castillo E, d'Alleves V, Broqua P, Pralong FP, Aubert ML. Chronic blockade of the melanocortin 4 receptor subtype leads to obesity independently of neuropeptide Y action, with no adverse effects on the gonadotropic and somatotropic axes. Endocrinology 2000; 141: 4419-4427.
Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Burn P, Lee F. Targeted disruption of the melanocortin-4- receptor results in obesity in mice. Cell 1997; 88: 131-141.
Schwartz MW, Seeley RJ, Campfield LA, Burn P, Beskin DG. Identification of leptin action in rat hypothalamus. J Clin Invest 1996; 98: 1101-1106.
Jang M, Mistry A, Swick AG, Romsos DR. Leptin rapidly inhibits hypothalamic neuropeptide Y secretion and stimulates corticotropin-releasing hormone secretion in adrenalectomized mice. J Nutr 2000; 130: 2813-2820.
Uehara Y, Shimizu H, Ohtani K, Sato N, Mori M. Hypothalamic corticotropin-releasing hormone is a mediator of the anorexigenic effect of leptin. Diabetes 1998; 47: 890-893.
Rivest S, Rivier C. The role of corticotropin-releasing factor and interleukin-1 in the regulation of neurons controlling reproductive functions. Endocr Rev 1995; 16: 177-199.
Gambacciani M, Yen SS, Rasmussen DD. GnRH release from the mediobasal hypothalamus: In vitro inhibition by corticotropin-releasing factor. Neuroendocrinology 1986; 43: 533-536.
Barbarino A, De Marinis L, Tofani A, Della Casa S, D'Amico C, Mancini A, Corselle SM, Sciuto R, Barini A. Corticotropin-releasing hormone inhibition of gonadotropin release and the effect of opiod blockade. J Clin Endocrinol Metab 1989; 68: 523-527.
Williams CL, Nishihara M, Thalabard JC, Grosser PM, Hotchkiss J, Knobil E. Corticotropin-releasing hormone pulse generator activity in the rhesus monkey. Neuroendocrinology 1990; 52: 133-137.
Jeong KH, Jacobson L, Widmaier EP, Majzoub JA. Normal suppression of the reproductive axis following stress in corticotropin-releasing hormone-deficiency mice. Endocrinology 1999; 140: 1702-1708.
Caraty A, Miller DW, Delaleu B, Martin GB. Stimulation of LH secretion in sheep by central administration of corticotrophin-releasing hormone. J Reprod Fertil 1997; 111: 249-257.
MacLusky NJ, Naftolin F, Leranth C. Immunocytochemical evidence for direct synaptic connections between corticotropin-releasing factor (CRF) and gonadotropin-releasing hormone (GnRH)-containing neurons in the preoptic area of the rat. Brain Res 1988; 439: 391-395.
Magni P, Vettor R, Pagano C, Calcagno A, Beretta E, Messi E, Zanisi M, Martini L, Motta M. Expression of a leptin receptor in immortalized gonadotropin- releasing hormone-secreting neurons. Endocrinology 1999; 140: 1581-1585.
Willesen MG, Kristensen P, Romer J. Co-localization of growth hormone secretagogue receptor and NPY mRNA in the arcuate nucleus of the rat. Neuroendocrinology 1999; 70: 306-316.
Iqbal J, Kurose Y, Canny B, Clarke IJ. Effects of central infusion of ghrelin on food intake and plasma levels of growth hormone, luteinizing hormone, prolactin, and cortisol secretion in sheep. Endocrinology 2006; 147: 510-519.
Asakawa A, Inui A, Kaga T, Yuzuriha H, Nagata T, Fujimiya M, Katsuura G, Makino S, Fujino MA, Kasuga M. A role of ghrelin in neuroendocrine and behavioral responses to stress in mice. Neuroendocrinology 2001; 74: 143-147.
Hahn TM, Breininger JF, Baskin DG, Schwartz MW. Coexpression of AGRP and NPY in fasting-activated hypothalamic neurons. Nat Neurosci 1998; 1: 271-272.
Vullienoz NR, Xia E, Xia-Zhang L, Wardlaw SL, Ferin M. Central infusion of agouti-related peptide suppresses pulsatile luteinizing hormone release in the ovariectomized rhesus monkey. Endocrinology 2005; 146: 784-789.
Zheng H, Corkern MM, Crousillac SM, Patterson LM, Phifer CB, Berthoud HR. Neurochemical phenotype of hypothalamic neurons showing Fos expression 23h after intracranial AgRP. Am J Physiol Regul Integr Comp Physiol 2002; 282: R1773-R178.
Smith JT, Acohido BV, Clifton DK, Steiner RA. KISS-1 neurones are direct targets for leptin in the ob/ob mouse. J Neuroendocrinol 2006; 18: 298-303.
